Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion

NCT02752633 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Adenine Phosphoribosyltransferase Deficiency

Interventions

DRUG: Allopurinol
DRUG: Febuxostat

Sponsor

Landspitali University Hospital

Collaborators

[object Object]
[object Object]